With a combination of granted patents covering both the revolutionary material platform and the commercialized, evidence-based products, along with newly filed applications, the intellectual property portfolio continues to strengthen and reinforcing Texray’s commitment to innovation in medical radiation safety.

Recent patent applications introduce with the potential to impact the field of radiation protection shielding systems significantly. The upcoming expansion of the product portfolio will include capital equipment and single-use products.

”Our continued growth of the patent portfolio is a testament to Texray’s dedication to innovation and the elevation of radiation protection for the medical professionals teams exposed to ionizing radiation. The latest patent applications complement existing granted patents, ensuring a strong foundation for both current and future product developments,” says Fredrik Gellerstedt, Co-Founder and Chief Technology Officer at Texray.

With a steadfast focus on research and technological development, Texray remains committed to advancing radiation protection, ensuring that medical professionals may perform their critical work without compromising their own health and safety.

Texray granted patents include Radiation Protective Material and Radiation Protective Devices in USA, EU, JP, AU.

About Texray

Texray develops the only radiation protection textile in the world, addressing the need for comfortable and functional personal protective equipment. The patented Texray material is presently utilized in products designed for medical professionals exposed to radiation during interventions. The Texray technology platform applies to various industries, including medical, nuclear, aviation, and space.

For more information, please contact:
Nina Offen Lantz